Your browser doesn't support javascript.
loading
Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: An analysis of the J-LINK study.
Komorizono, Yasuji; Hosoyamada, Kaori; Imamura, Naoko; Kajiya, Shoko; Hashiguchi, Yasuhiro; Ueyama, Norio; Shinmaki, Hirohiko; Koriyama, Nobuyuki; Tsukasa, Masako; Kamada, Tetsuro.
Afiliação
  • Komorizono Y; Department of Hepatology, Nanpuh Hospital, Kagoshima, Japan.
  • Hosoyamada K; Department of Internal Medicine, Kagoshima Kouseiren Hospital, Kagoshima, Japan.
  • Imamura N; Jiaikai Clinic, Kagoshima, Japan.
  • Kajiya S; Uenomachi-Kajiya Clinic, Kagoshima, Japan.
  • Hashiguchi Y; Tempozan Naika Medical Clinic, Kagoshima, Japan.
  • Ueyama N; Ueyama Clinic, Kagoshima, Japan.
  • Shinmaki H; Shinmaki Clinic, Kagoshima, Japan.
  • Koriyama N; Department of Diabetes and Endocrinology, National Hospital Organization, Kagoshima Medical Center, Kagoshima, Japan.
  • Tsukasa M; Department of Diabetes and Endocrinology, Nanpuh Hospital, Kagoshima, Japan.
  • Kamada T; Center of Diabetes, Idzuro-Imamura Hospital, Kagoshima, Japan.
Diabetes Obes Metab ; 23(3): 832-837, 2021 03.
Article em En | MEDLINE | ID: mdl-33236464
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Metformina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Metformina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article